Bausch Health to Announce First Quarter 2026 Results on April 29, 2026
LAVAL, QC, March 31, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release first quarter 2026 financial results after market close on Wednesday, April 29, 2026. Bausch Health will host a live conference call and webcast at 5:00 p.m. U.S. EDT to discuss results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.
Date: Wednesday, April 29, 2026
Time: 5:00 p.m. U.S. EDT
A replay of the conference call will be available on the investor relations website.
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors.
Investor Contact:
|
Media Contact:
|
|
Garen Sarafian |
Katie Savastano |
|
(877) 281-6642 (toll-free) |
(908) 541-3785 |
|
BHC-FINANCIAL |
SOURCE Bausch Health Companies Inc.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
NASDAQ TRADE HALT CONTINUES <UCFI.O> REASON NOT AVAILABLE AT 09:00 AM
Lifecore Biomedical To Be Acquired By Webster Equity Partners >LFCR
UK Chancellor Healey: We will maintain control of Britain's finances
Crypto prices
More
